(Q43807995)

27 November 2017

title

Fatal esophageal perforation with alendronate (English)

1 reference

27 November 2017

Famularo G

1

1 reference

27 November 2017

De Simone C

series ordinal

2

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

The American Journal of Gastroenterology

27 November 2017

published in

1 reference

27 November 2017

volume

96

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

3212-3213

1 reference

Esophagitis associated with the use of alendronate

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05291.X

Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05291.X

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05291.X

Comparative study of potential for bisphosphonates to damage gastric mucosa of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05291.X

Esophageal irritation due to alendronate sodium tablets: possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.05291.X

10.1111/J.1572-0241.2001.05291.X

21 January 2018

Identifiers

DOI

1 reference

release_7buk56qe25ch7g5d3t3jl7dlhm

27 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7buk56qe25ch7g5d3t3jl7dlhm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference